Scott Power of Morgans has highlighted QRX as one of two biotech...

Scott Power of Morgans has highlighted QRX as one of two biotech stocks to seek out because of significant near-term news flows:

http://www.morgans.com.au/Blog/2014/April/Morgans-Life-Science-Index.aspx

To quote:

"The Morgans Life Sciences Index...(like the NASDAQ Biotech Index) is retracing after a very good run through the second half of 2013. As the Index becomes increasingly stock-specific and patchy, seek out companies with near-term positive news flow. Two such companies are Qrxpharma Ltd - QRX (Advisory Committee meeting this month to discuss and recommend MOXDUO) and Neuren Pharmaceutical - NEU (completing recruitment for Retts Phase 2 trial in 2QCY14)."